Basel, United Kingdom

Sonal Patel



Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 48(Granted Patents)


Location History:

  • Slough, GB (2012)
  • Basel, GB (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sonal Patel

Introduction

Sonal Patel is a notable inventor based in Basel, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target hyperproliferative disorders such as cancer. With a total of 2 patents to his name, Patel's work is paving the way for new therapeutic methods.

Latest Patents

Patel's latest patents focus on combinations of phosphoinositide 3-kinase (PI3K) inhibitor compounds and chemotherapeutic agents. These patents detail methods of using these combinations for the diagnosis, prevention, or treatment of hyperproliferative disorders in mammalian cells. The compounds include stereoisomers, geometric isomers, tautomers, metabolites, and pharmaceutically acceptable salts, showcasing a comprehensive approach to cancer treatment.

Career Highlights

Throughout his career, Sonal Patel has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Patel has collaborated with several professionals in his field, including Marcia Belvin and Lori Friedman. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Sonal Patel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to advance the treatment options available for serious health conditions such as cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…